20th International Conference on Alzheimer's Drug Discovery

20th International Conference on Alzheimer's Drug Discovery is organized by Alzheimers Drug Discovery Foundation (ADDF) and will be held from Sep 16 - 17, 2019 at Hyatt Regency Jersey City, Jersey City, New Jersey, United States of America.

Audience
The 2018 edition of this conference attracted close to 170 attendees from around the world. Attendees included:
• Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases and CNS
• Business development and licensing professionals
• Alliance management professionals
• Venture capitalists and other investors
• Graduate students, PhD candidates and post-doctoral fellows.

Description
The purpose for this Conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.

Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.

Objectives
• Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.
• Increase networking opportunities for scientists to share information and resources.
• Foster interdisciplinary and public-private partnerships and alliances.

Additional details will be posted as soon as they are available.